Empirical vs Tailored Therapy for H. Pylori Infection

Conditions:   Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation;   Helicobacter Pylori Infection Interventions:   Combination Product: triple therapy;   Combination Product: quadruple therapy;   Diagnostic Test: dual-priming oligonucleotide-based multiplex (DPO)-PCR test Sponsor:   Seoul National University Hospital Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials